Published in J Digit Imaging on November 01, 1999
Radiologist's clinical information review workstation interfaced with digital dictation system. J Digit Imaging (2000) 0.98
Speech recognition interface to a hospital information system using a self-designed visual basic program: initial experience. J Digit Imaging (2002) 0.93
The effectiveness of service delivery initiatives at improving patients' waiting times in clinical radiology departments: a systematic review. J Digit Imaging (2014) 0.83
RadStation: client-based digital dictation system and integrated clinical information display with an embedded Web-browser. Proc AMIA Symp (2000) 0.79
Integrated voice recognition and picture archiving and communication system: development and early experience. J Digit Imaging (2001) 0.76
Creation of a software application for the clinical radiologist. J Digit Imaging (2001) 0.75
Picture archiving and communication system activities at the Mayo Clinic Rochester. J Digit Imaging (1998) 1.67
Processes involved in reading imaging studies: workflow analysis and implications for workstation development. J Digit Imaging (1997) 1.33
Image quality of a digital chest radiography system based on a selenium detector. Med Phys (1994) 1.25
A new asymmetric screen-film combination for conventional chest radiography: evaluation in 50 patients. AJR Am J Roentgenol (1993) 1.13
Performance and function of a high-speed multiple star topology image management system at Mayo Clinic Scottsdale. J Digit Imaging (1999) 1.09
Selenium-based digital radiography of the chest: radiologists' preference compared with film-screen radiographs. AJR Am J Roentgenol (1995) 0.91
Objective performance characteristics of a new asymmetric screen-film system. Med Phys (1994) 0.89
Reporting and communications. Radiol Clin North Am (1996) 0.88
The cardio-toxicity of isoprenaline during hypoxia. Br J Pharmacol (1969) 2.94
Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin Pharmacol Ther (1987) 2.92
Screening for lung cancer. A critique of the Mayo Lung Project. Cancer (1991) 2.47
Benign teratomas of the mediastinum. J Thorac Cardiovasc Surg (1983) 2.46
Lung nodule enhancement at CT: multicenter study. Radiology (2000) 2.32
Lung cancer screening: the Mayo program. J Occup Med (1986) 2.13
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis (1984) 2.13
Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc (1977) 2.03
Pharmacologic rationale for regional drug delivery. J Clin Oncol (1984) 1.82
Potential roles for preclinical pharmacology in phase I clinical trials. Cancer Treat Rep (1986) 1.79
Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res (1994) 1.75
Lung cancer detected during a screening program using four-month chest radiographs. Radiology (1983) 1.64
CT of the pulmonary nodule: a cooperative study. Radiology (1986) 1.52
A national study of cross infection control: 'are we clean enough?'. Br Dent J (2009) 1.51
Pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS and related disorders. J Clin Pharmacol (1988) 1.51
Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys (1998) 1.50
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. J Natl Cancer Inst (1990) 1.49
Lung nodules: dual-kilovolt peak analysis with CT--multicenter study. Radiology (2000) 1.49
Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Cancer Res (1983) 1.47
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res (1981) 1.45
Performance and function of a desktop viewer at Mayo Clinic Scottsdale. J Digit Imaging (2000) 1.41
Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med (1983) 1.38
Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo. Lancet (1985) 1.35
Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res (1987) 1.34
Roentgenographic findings in thoracic aortic dissection. Mayo Clin Proc (1979) 1.30
Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Drug Metab Dispos (1997) 1.25
Comparison of whole lung tomography and computed tomography for detecting pulmonary nodules. AJR Am J Roentgenol (1978) 1.21
Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes. Clin Pharmacol Ther (1980) 1.21
Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res (1980) 1.20
Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology (1999) 1.14
Computed tomography of the body: initial clinical trial with the EMI prototype. AJR Am J Roentgenol (1976) 1.14
Dextran sulfate is poorly absorbed after oral administration. Ann Intern Med (1989) 1.13
The effects of nutritional and hormonal factors on the fatty acid synthetase level of rat liver. J Biol Chem (1969) 1.11
The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Drug Metab Dispos (1997) 1.09
Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection. J Clin Pharmacol (1986) 1.09
Performance and function of a high-speed multiple star topology image management system at Mayo Clinic Scottsdale. J Digit Imaging (1999) 1.09
The cysteine desulfhydrase of Salmonella typhimurium. Kinetic and catalytic properties. J Biol Chem (1973) 1.06
Dumbbell neurogenic tumors of the mediastinum. Diagnosis and management. Mayo Clin Proc (1978) 1.06
Meniscal cysts: detection with high-resolution sonography. AJR Am J Roentgenol (1998) 1.05
Computed tomography of the mediastinum. Radiology (1978) 1.05
Malignant germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg (1985) 1.04
Improved therapeutic index of bleomycin when administered by continuous infusion in mice. Cancer Treat Rep (1978) 1.02
Regulatory features of the cysteine desulfhydrase of Salmonella typhimurium. Biochim Biophys Acta (1973) 1.01
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther (1983) 1.00
Mayo Lung Project: evaluation of lung cancer screening through December 1979. Mayo Clin Proc (1981) 1.00
A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer. Int J Radiat Oncol Biol Phys (1985) 0.99
Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases. Cancer (1986) 0.97
Understanding consequences of concurrent therapies. JAMA (1993) 0.96
The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther (1987) 0.94
The interrelation between DNA synthesis rates and DNA polymerases bound to the nuclear matrix in synchronized HeLa cells. J Biol Chem (1985) 0.94
Rates of DNA synthesis during the S-phase of HeLa cells. J Biol Chem (1978) 0.93
Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther (1984) 0.93
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy. Clin Cancer Res (1996) 0.91
Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Antimicrob Agents Chemother (1998) 0.91
Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences. Cancer Chemother Pharmacol (1995) 0.91
A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240). Cancer Res (1983) 0.91
Rifampin and rifabutin and their metabolism by human liver esterases. Xenobiotica (1997) 0.91
Extrapolation of animal toxicity to humans: interspecies comparisons in drug development. Regul Toxicol Pharmacol (1990) 0.90
Toxicity, metabolism, DNA incorporation with lack of repair, and lactate production for 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in U-937 and MOLT-4 cells. Mol Pharmacol (1994) 0.90
A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation. Int J Radiat Oncol Biol Phys (1984) 0.90
Metabolism of rifabutin and its 25-desacetyl metabolite, LM565, by human liver microsomes and recombinant human cytochrome P-450 3A4: relevance to clinical interaction with fluconazole. Antimicrob Agents Chemother (1997) 0.90
Preferential binding of DNA primase to the nuclear matrix in HeLa cells. J Biol Chem (1986) 0.90
Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clin Pharmacol Ther (1985) 0.89
Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole. Am J Clin Oncol (1997) 0.89
Single-stranded regions in regenerating rat liver DNA. Nature (1976) 0.89
Effect of albumin on the estimation, in vitro, of phenytoin Vmax and Km values: implications for clinical correlation. J Pharmacol Exp Ther (1997) 0.89
Recovery after prolonged oliguria due to ethylene glycol intoxication. The prognostic value of serial, percutaneous renal biopsy. Arch Intern Med (1970) 0.89
Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J Natl Cancer Inst (1988) 0.88
Contribution of indirect computed tomography venography to computed tomography angiography of the chest for the diagnosis of thromboembolic disease in two United States emergency departments. J Thromb Haemost (2003) 0.88
High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. Cancer Res (1981) 0.87
Unsuspected early pregnancy at hysterosalpingography. Fertil Steril (2001) 0.87
Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone. Clin Pharmacol Ther (1998) 0.87
Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer. Cancer Chemother Pharmacol (1993) 0.86
Pharmacology of intraperitoneal chemotherapy. Cancer Invest (1983) 0.86
Receptor binding of PDGF-AA and PDGF-BB, and the modulation of PDGF receptors by TGF-beta, in human periodontal ligament cells. J Cell Physiol (1995) 0.86
Distributed model for drug delivery to CSF and brain tissue. Am J Physiol (1983) 0.86
Radiographic detection of thymoma. AJR Am J Roentgenol (1980) 0.86
Computed tomography of the thorax. Current perspectives. Chest (1983) 0.86
Routine chest roentgenography in pregnancy. JAMA (1978) 0.85
Structure of parental deoxyribonucleic acid of synchronized HeLa cells. Biochemistry (1977) 0.85
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512). Cancer Res (1988) 0.85
Use of computed tomography in the detection of pulmonary nodules. Mayo Clin Proc (1977) 0.84
Transitional cell carcinoma obstructing a calyceal diverticulum: unusual presentation as a peripheral cystic mass. J Ultrasound Med (1999) 0.84
In vitro human tissue models in risk assessment: report of a consensus-building workshop. Toxicol Sci (2001) 0.84
Pulmonary lymphangiomyomatosis. Lung (1980) 0.84
Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res (1986) 0.84
Aphidicolin-inducible common fragile-site expression: results from a population survey of twins. Am J Hum Genet (1992) 0.83
Differentiation of promyelocytic (HL-60) cells into mature granulocytes: mitochondrial-specific rhodamine 123 fluorescence. J Cell Biol (1983) 0.83
The cysteine desulfhydrase of Salmonella typhimurium. Formation of an altered enzyme by cryloysis. J Biol Chem (1973) 0.83
Deoxyribonucleic acid structure in human diploid fibroblasts stimulated to proliferate. J Biol Chem (1977) 0.83
Cell cycle and proliferation dynamics of adult rat oligodendrocytes. J Neurosci Res (1992) 0.83
Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver. J Pharmacol Exp Ther (1981) 0.83
The evaluation of pulmonary parenchymal abnormalities by tomography. Radiol Clin North Am (1976) 0.83
Applications of light scatter to separation of stem cells. Blood Cells (1980) 0.83
Accuracy of assessment of the extent of examination by experienced colonoscopists. Gastrointest Endosc (1992) 0.82
Gas chromatographic-mass spectrometric method for routine monitoring of 5-fluorouracil in plasma of patients receiving low-level protracted infusions. J Chromatogr (1992) 0.82
Identification of 2,6-xylidine as a major lidocaine metabolite in human liver slices. Drug Metab Dispos (1996) 0.82
Role of computed tomography in evaluation of intrathoracic lesions. J Thorac Cardiovasc Surg (1980) 0.82
Reappraisal of some dosage adjustment guidelines. Cancer Treat Rep (1987) 0.82